Research progress on neuregulin 4 regulating lipid metabolism

doi:10.16352/j.issn.1001-6325.2023.10.1599

Abstract

Abstract: Neuregulin 4 (NRG4) is a novel fat secretion factor that is mainly expressed and secreted in brown fat. NRG4 specifically binds to epidermal growth factor receptor 4 (ErbB4) on hepatocyte membranes and activates downstream signaling pathways to relieve hepatic steatosis by inhibiting de novo synthesis of lipids, increasing fatty acid oxidation and ketogenesis. NRG4 can also regulate the expression of adipose tissue genes, reduce the insulin resistance of adipocytes, regulate vascular remodeling in adipose tissue, and benefit lipid metabolism. The favorable regulation of lipids by NRG4 may improve obesity-related metabolic disorders and might be a potential therapeutic target for metabolic diseases such as non-alcoholic fatty liver, diabetes, and atherosclerosis.

Key words: neuregulin 4(NRG4), lipid metabolism, adipose tissue

CLC Number:

WANG Xueran, TIAN Zongyuan, LIU Ruixia. Research progress on neuregulin 4 regulating lipid metabolism[J]. Basic & Clinical Medicine, 2023, 43(10): 1599-1603.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.10.1599

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I10/1599

References

[1]Harari D, Tzahar E, Romano J, et al. Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase[J]. Oncogene, 1999, 18: 2681-2689.
[2]Wang GX, Zhao XY, Meng ZX, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeos-tasis through attenuation of hepatic lipogenesis[J]. Nat Med, 2014, 20: 1436-1443.
[3]Chen Z, Wang GX, Ma SL, et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders[J]. Mol Metab, 2017, 6: 863-872.
[4]Zhu B, Mei W, Jiao T, et al. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet[J]. Eur J Pharmacol, 2020, 884: 173350. doi: 10.1016/j.ejphar.2020.173350.
[5]Wang H, Wang L, Hu F, et al. Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway[J]. Cardiovasc Diabetol, 2022, 21: 205. doi: 10.1186/s12933-022-01643-0.
[6]Comas F, Martínez C, Sabater M, et al. Neuregulin 4 is a novel marker of beige adipocyte precursor cells in human adipose tissue[J]. Front Physiol, 2019, 10: 39. doi: 10.3389/fphys.2019.00039.
[7]Li Y, Jin L, Jiang F, et al. Mutations of NRG4 contribute to the pathogenesis of nonalcoholic fatty liver disease and related metabolic disorders[J]. Diabetes, 2021, 70: 2213-2224.
[8]Díaz-Sáez F, Blanco-Sinfreu C, Archilla-Ortega A, et al. Neuregulin 4 downregulation induces insulin resistance in 3T3-L1 adipocytes through inflammation and autophagic degradation of GLUT4 vesicles[J]. Int J Mol Sci, 2021, 22: 12960. doi: 10.3390/ijms222312960.
[9]Zhang L, Bai M, Tang H, et al. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice[J]. Life Sci, 2019, 217: 185-192.
[10]Martínez C, Latorre J, Ortega F, et al. Serum neuregulin 4 is negatively correlated with insulin sensitivity in humans and impairs mitochondrial respiration in HepG2 cells[J]. Front Physiol, 2022, 13: 950791. doi: 10.3389/fphys.2022.950791.
[11]Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling[J]. Nat Commun, 2022, 13: 5117. doi: 10.1038/s41467-022-32658-6.
[12]Shi L, Li Y, Xu X, et al. Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and athero-sclerosis in male mice[J]. Nat Metab, 2022, 4: 1573-1590.
[13]Guo L, Zhang P, Chen Z, et al. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression[J]. J Clin Invest, 2017, 127: 4449-4461.
[14]De Munck TJI, Boesch M, Verhaegh P, et al. Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?[J]. PLoS One, 2021, 16: e0251822. doi: 10.1371/journal.pone.0251822.
[15]Tutunchi H, Mobasseri M, Aghamohammadzadeh N, et al. Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): a case-control study [J]. Int J Clin Pract, 2021, 75: e14555. doi: 10.1111/ijcp.14555.
[16]Cai C, Lin M, Xu Y, et al. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study[J]. BMC Med, 2016, 14:165. doi: 10.1186/s12916-016-0703-6.
[17]Yan P, Xu Y, Wan Q, et al. Plasma neuregulin 4 levels are associated with metabolic syndrome in patients newly diagnosed with type 2 diabetes mellitus[J]. Dis Markers, 2018, 2018: 6974191. doi: 10.1155/2018/6974191.
[18]Guo D, Liu J, Zhang P, et al. Adiposity measurements and metabolic syndrome are linked through circulating neuregulin 4 and adipsin levels in obese adults[J]. Front Physiol, 2021, 12: 667330. doi: 10.3389/fphys.2021.667330.
[19]Li M, Chen Y, Jiang J, et al. Elevated serum neuregulin 4 levels in patients with hyperthyroidism[J]. Endocr Connect, 2019, 8: 728-735.
[20]魏巍, 张旭, 李婉娇, 等. 临床甲亢和亚临床甲亢患者血清Nrg4,TSK水平与血脂、甲状腺激素和基础代谢率的相关性分析[J]. 现代检验医学杂志, 2022, 37: 38-42+47.
[21]Li Q, Li C, Jin J, et al. Clinical significance of neuregulin 4, Afamin, and SERPINB1 in gestational diabetes mellitus and their relationship with insulin resistance[J]. Evid Based Complement Alternat Med, 2022, 2022: 2829662. doi: 10.1155/2022/2829662.
[22]Kralisch S, Hoffmann A, Kratzsch J, et al. The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus[J]. Diabetes Metab, 2018, 44: 150-154.
[23]Zhang L, Lu B, Wang W, et al. Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus[J]. Ther Adv Endocrinol Metab, 2021, 12: 20420188211049614. doi: 10.1177/20420188211049614.
[24]杨海荣, 丰树菊, 杜鹏琳, 等. 血清Spexin、神经调节蛋白4表达与妊娠期糖尿病的相关性[J]. 广东医学, 2021, 42: 1467-1471.
[25]高丽欣, 宋燕, 付凤仙. 妊娠期糖尿病患者血清神经调节蛋白4和Afamin水平变化及临床意义[J]. 中华实用诊断与治疗杂志, 2020, 34: 896-898.